Delivery Order SPE2DB22D9309-SPE2DB24FAE14
Award Date
11/20/23
Potential Completion Date
12/12/23
Potential Value
$53K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifty-three thousand three hundred eighteen dollars and twenty-four cents ($53,318.24) by the Defense Logistics Agency. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular award, DMS Pharmaceutical Group will provide 4563201012 MACI 3CM X...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide 4563200330 MACI 3CM X 5CM IMPLANT SHEETS. The $53,318.24 order has a completion date of January 9, 2024 and was awarded on December 15, 2023. DMS Pharmaceutical Group will deliver the implant sheets to the Defense Logistics Agency location in Park Ridge, Illinois. As a woman-owned small business, DMS Pharmaceutical Group is the...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $106,636.46 under an indefinite delivery contract with the Defense Logistics Agency to supply 4563200327 MACI 3CM X 5CM IMPLANT SHEET 2S. The delivery order has a completion date of January 9, 2024. DMS Pharmaceutical Group Inc. will fulfill this order as a woman owned small business and woman owned business. Under the indefinite delivery contract with potential value up to $5 million through December 2025,...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifty-three thousand three hundred eighteen dollars and twenty-four cents ($53,318.24) by the Defense Logistics Agency to supply MACI 3CM X 5CM IMPLANT SHEETS. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifty-three thousand three hundred eighteen dollars and twenty-four cents ($53,318.24) by the Defense Logistics Agency to provide MACI 3CM X 5CM IMPLANT SHEETS. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply various medical products including atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency for $106,636.46 to supply MACI 3CM X 5CM IMPLANT SHEET 2S. The delivery order has a completion date of December 4, 2023 and was awarded on November 9, 2023. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency, valued at up to $5 million through December 2025, to provide pharmaceuticals and...
This is a delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract is for the delivery of MACI 3CM X 5CM IMPLANT SHEETS, with a ceiling value of $57,317.20 and a performance period ending on August 28, 2024. The contract type is Firm Fixed Price. DMS Pharmaceutical Group Inc. is the prime contractor, and there is no set-aside designation for this award. This...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifty-three thousand three hundred eighteen dollars and twenty-four cents ($53,318.24) by the Defense Logistics Agency to provide MACI 3CM X 5CM IMPLANT SHEETS. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply various medical products including atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous...
The U.S. Defense Logistics Agency (DLA) awarded a $57,317.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of MACI 3CM X 5CM IMPLANT SHEETS. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including...
The Defense Logistics Agency has awarded a $57,317.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4563711559 MACI 3CM X 5CM implant sheets. This delivery order was issued under an existing indefinite delivery contract held by DMS Pharmaceutical Group to provide a variety of pharmaceutical and medical products to support the operations of military treatment facilities worldwide. DMS Pharmaceutical Group has extensive...